Cargando…

Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia

BACKGROUND: Viral infections are the most common diseases. Of them, human immunodeficiency virus (HIV), hepatitis B viruses (HBV), and hepatitis C viruses (HCV) are common. When HBV or HCV becomes co-morbid with HIV, they lead to severe forms of a disease and rapid death. OBJECTIVE: This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayelign, Meseret, Aynalem, Melak, Berhane, Nega
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593689/
https://www.ncbi.nlm.nih.gov/pubmed/34795539
http://dx.doi.org/10.2147/HMER.S337817
_version_ 1784599803973337088
author Ayelign, Meseret
Aynalem, Melak
Berhane, Nega
author_facet Ayelign, Meseret
Aynalem, Melak
Berhane, Nega
author_sort Ayelign, Meseret
collection PubMed
description BACKGROUND: Viral infections are the most common diseases. Of them, human immunodeficiency virus (HIV), hepatitis B viruses (HBV), and hepatitis C viruses (HCV) are common. When HBV or HCV becomes co-morbid with HIV, they lead to severe forms of a disease and rapid death. OBJECTIVE: This study aimed to determine the seroprevalence and associated factors of HBV and HCV among HIV-positive study participants. METHODS: A cross-sectional study was conducted among 81 individuals, and a non-randomized purposive sampling technique was used. From each study participant, sociodemographic and clinical data were gathered by using a pretested questionnaire and data collection sheet, respectively. Further, a venous blood sample was collected for viral load count, and HBV and HCV determination. To keep the quality of test results, commercially prepared quality control samples were used. The data were entered to EPI-Info version 7 and analyzed by using SPSS version 20. The descriptive data were summarized in percentages, median, and IQR. Logistic regression was analyzed to determine associated factors. To say the data were statistically significant, the p-values should be less than 0.05. RESULTS: A total of 81 study participants were included. Of them, 56.8% (46/81) and 67.9% (55/81) were female and urban residents, respectively. The prevalence of hepatitis co-infection was 21% (95% CI: 17%, 23%). Further, the prevalence of HBV/HIV and HCV/HIV was 13.5% (95% CI: 10.5%, 16.5%) and 8.6% (95% CI: 5.6%, 11.6%), respectively. Wise use of highly active antiretroviral therapy (HAART) 0.01 (0.00, 0.213) was a preventive factor to hepatitis infection. CONCLUSION AND RECOMMENDATION: The HBV and HCV co-infection among HIV-positive patients was a significant public health concern. Also, having wise use of HAART can reduce exposure to hepatitis co-infection. Therefore, clear strategies on hepatitis screening and wise use of HAART to HIV would be critical.
format Online
Article
Text
id pubmed-8593689
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85936892021-11-17 Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia Ayelign, Meseret Aynalem, Melak Berhane, Nega Hepat Med Original Research BACKGROUND: Viral infections are the most common diseases. Of them, human immunodeficiency virus (HIV), hepatitis B viruses (HBV), and hepatitis C viruses (HCV) are common. When HBV or HCV becomes co-morbid with HIV, they lead to severe forms of a disease and rapid death. OBJECTIVE: This study aimed to determine the seroprevalence and associated factors of HBV and HCV among HIV-positive study participants. METHODS: A cross-sectional study was conducted among 81 individuals, and a non-randomized purposive sampling technique was used. From each study participant, sociodemographic and clinical data were gathered by using a pretested questionnaire and data collection sheet, respectively. Further, a venous blood sample was collected for viral load count, and HBV and HCV determination. To keep the quality of test results, commercially prepared quality control samples were used. The data were entered to EPI-Info version 7 and analyzed by using SPSS version 20. The descriptive data were summarized in percentages, median, and IQR. Logistic regression was analyzed to determine associated factors. To say the data were statistically significant, the p-values should be less than 0.05. RESULTS: A total of 81 study participants were included. Of them, 56.8% (46/81) and 67.9% (55/81) were female and urban residents, respectively. The prevalence of hepatitis co-infection was 21% (95% CI: 17%, 23%). Further, the prevalence of HBV/HIV and HCV/HIV was 13.5% (95% CI: 10.5%, 16.5%) and 8.6% (95% CI: 5.6%, 11.6%), respectively. Wise use of highly active antiretroviral therapy (HAART) 0.01 (0.00, 0.213) was a preventive factor to hepatitis infection. CONCLUSION AND RECOMMENDATION: The HBV and HCV co-infection among HIV-positive patients was a significant public health concern. Also, having wise use of HAART can reduce exposure to hepatitis co-infection. Therefore, clear strategies on hepatitis screening and wise use of HAART to HIV would be critical. Dove 2021-11-11 /pmc/articles/PMC8593689/ /pubmed/34795539 http://dx.doi.org/10.2147/HMER.S337817 Text en © 2021 Ayelign et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ayelign, Meseret
Aynalem, Melak
Berhane, Nega
Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia
title Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia
title_full Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia
title_fullStr Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia
title_full_unstemmed Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia
title_short Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia
title_sort hepatitis and hiv co-infection at university of gondar specialized referral hospital: northwest ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593689/
https://www.ncbi.nlm.nih.gov/pubmed/34795539
http://dx.doi.org/10.2147/HMER.S337817
work_keys_str_mv AT ayelignmeseret hepatitisandhivcoinfectionatuniversityofgondarspecializedreferralhospitalnorthwestethiopia
AT aynalemmelak hepatitisandhivcoinfectionatuniversityofgondarspecializedreferralhospitalnorthwestethiopia
AT berhanenega hepatitisandhivcoinfectionatuniversityofgondarspecializedreferralhospitalnorthwestethiopia